SCHEMBL1489012

SCHEMBL1489012

CC(=O)N(O)C(C)C=Cc1cccc(S(=O)(=O)Nc2ccc(Cl)cc2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 10/20 0.59
HDAC8 Q9BY41 10/20 0.59
HDAC3 O15379 8/20 0.59
HDAC4 P56524 8/20 0.59
HDAC7 Q8WUI4 8/20 0.59
HDAC2 Q92769 8/20 0.59
HDAC10 Q969S8 8/20 0.59
HDAC11 Q96DB2 8/20 0.59
HDAC6 Q9UBN7 8/20 0.59
HDAC9 Q9UKV0 8/20 0.59
HDAC5 Q9UQL6 8/20 0.59
MAPT P10636 3/20 0.52
TP53 P04637 1/20 0.52
GAA P10253 1/20 0.52
THRB P10828 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
PGR P06401 3/20 0.47
LMNA P02545 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
BRD4 O60885 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1489010 1.00 HDAC1 (0.59) HDAC1HDAC8HDAC3HDAC4HDAC7
SCHEMBL1489223 0.91 HDAC3 (0.55) HDAC1HDAC8HDAC3HDAC4HDAC7
SCHEMBL1489222 0.91 HDAC3 (0.55) HDAC1HDAC8HDAC3HDAC4HDAC7
SCHEMBL1489015 0.90 CYP19A1 (0.51) HDAC1HDAC8HDAC3HDAC4HDAC7
SCHEMBL1489017 0.90 CYP19A1 (0.51) HDAC1HDAC8HDAC3HDAC4HDAC7
SCHEMBL1489093 0.80 HDAC1 (0.46) HDAC1HDAC8HDAC3HDAC4HDAC7
SCHEMBL1489089 0.80 HDAC1 (0.46) HDAC1HDAC8HDAC3HDAC4HDAC7
SCHEMBL14161788 0.80 HDAC4 (0.60) HDAC1HDAC8HDAC3HDAC4HDAC7
SCHEMBL1489165 0.79 MAPT (0.48) HDAC1HDAC8HDAC3HDAC4HDAC7
SCHEMBL1489163 0.79 MAPT (0.48) HDAC1HDAC8HDAC3HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110077305-A1 5-LIPOXYGENASE INHIBITORS FYLOCEL LTD. (GB) 2011-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110077305-A1 5-LIPOXYGENASE INHIBITORS ALOX12, ALOX15, ALOX5 HDAC1 1610/4885HDAC8 2559/4885HDAC3 2267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.